ENTA β€” ENANTA PHARMACEUTICALS INC

Ownership history in PDT Partners, LLC  Β·  21 quarters on record

This page tracks every 13F SEC filing in which PDT Partners, LLC reported a position in ENANTA PHARMACEUTICALS INC (ENTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.1% (2020 Q2)
πŸ“Š Avg. % of fund
0.05%
πŸ“… First filed
2015 Q1
πŸ“… Last filed
2025 Q4
⏱ Quarters held
21

Position Intelligence

PDT Partners, LLC Γ— ENTA AI Analytics

πŸ“ˆ PDT Partners, LLC outperformed the S&P 500 by +2.4% annually on this ENTA position. Timing score: 65% (13/20 decisions correct). Average cost basis: $17.25. Maximum drawdown during holding period: –90.3%.

πŸ“ˆ Position Alpha vs SPY
+2.4%
annualised excess return

βœ… Outperformed SPY on this position by 2.4% ann.
10 quarters analyzed

⏱️ Timing Score
65%

βœ… Decent timing β€” more right than wrong on entries and exits.
13 of 20 add/trim decisions correct

πŸ’° Entry Quality
$17.25
-8.6% vs current ($15.77)

Best entry: $5.52 (2025 Q1)  Β·  Worst: $50.21 (2020 Q2)

πŸ›‘οΈ Drawdown Resilience
–90.3%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
43%
buy-side decisions

9 adds Β· 12 trims. Bought during 7 of 12 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.07% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ENTA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 69,197 -16,825 -19.6% 0.07% $1.1M $15.77
2025 Q3 REDUCED 86,022 -730 -0.8% 0.06% $1.0M $11.97
2025 Q2 REDUCED 86,752 -19,448 -18.3% 0.04% $656K $7.56
2025 Q1 ADDED 106,200 +72,751 +217.5% 0.04% $586K $5.52
2024 Q4 ADDED 33,449 +107 +0.3% 0.02% $192K $5.75
2024 Q3 REDUCED 33,342 -2,901 -8.0% 0.03% $345K $10.36
2024 Q2 REDUCED 36,243 -3,484 -8.8% 0.04% $470K $12.97
2024 Q1 REDUCED 39,727 -23,498 -37.2% 0.07% $694K $17.46
2023 Q4 REDUCED 63,225 -4,093 -6.1% 0.07% $595K $9.41
2023 Q3 ADDED 67,318 +39,699 +143.7% 0.09% $752K $11.17
11 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ENTA

As of 2025 Q4 β€” sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.41% Stonepine Capital Management, LLC 3Y 7Y 1.15% Deep Track Capital, LP 3Y 0.55% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 0.21% Hillsdale Investment Management Inc. 3Y 7Y 0.18% Opaleye Management Inc. 3Y 7Y 0.16% Persistent Asset Partners Ltd 0.12% Sio Capital Management, LLC 3Y 7Y 0.1% Informed Momentum Co LLC 3Y 7Y 0.07% ADAR1 Capital Management, LLC 0.05%
← Back to PDT Partners, LLC Holdings